» Articles » PMID: 1360812

Smoking and Schizophrenia

Overview
Journal Schizophr Res
Specialty Psychiatry
Date 1992 Dec 1
PMID 1360812
Citations 59
Authors
Affiliations
Soon will be listed here.
Abstract

Several studies have shown that patients with schizophrenia have an extremely high prevalence of smoking, almost 90%, compared to only 33% in the general population and 45-70% in patients with other psychiatric diagnoses. The reasons for the high prevalence of smoking among schizophrenics is unknown, but it is likely that smoking behavior in schizophrenia may be a complex process, related to numerous interrelationships between the psychopathological, biochemical, and neuropharmacological aspects of smoking and of schizophrenia.

Citing Articles

The Relationship Between Schizotypal Personality Traits and Temporal Discounting: The Role of the Date/Delay Effect.

Keidel K, Murawski C, Pantelis C, Ettinger U Schizophr Bull. 2025; 51(Supplement_2):S64-S73.

PMID: 40037816 PMC: 11879521. DOI: 10.1093/schbul/sbad110.


Modulation of mGlu5 reduces rewarding associative properties of nicotine via changes in mesolimbic plasticity: Relevance to comorbid cigarette smoking in psychosis.

Peeters L, Wills L, Cuozzo A, Ivanich K, Turney S, Bullock L Pharmacol Biochem Behav. 2024; 239():173752.

PMID: 38521210 PMC: 11088493. DOI: 10.1016/j.pbb.2024.173752.


The causal relationship between severe mental illness and risk of lung carcinoma.

Chen X, Wang S, Shen W Medicine (Baltimore). 2024; 103(11):e37355.

PMID: 38489734 PMC: 10939700. DOI: 10.1097/MD.0000000000037355.


Smoking, Symptoms Improvement, and Total Antioxidant Capacity in Patients with Drug-naive First-episode Schizophrenia: A Prospective Cohort Study.

Gao Z, Xiu M, Liu J, Wu F, Zhang X Curr Neuropharmacol. 2023; 22(10):1733-1741.

PMID: 37859307 PMC: 11284715. DOI: 10.2174/1570159X22666231019105328.


Hypercoagulable state in patients with schizophrenia: different effects of acute and chronic antipsychotic medications.

Zheng C, Liu H, Tu W, Lin L, Xu H Ther Adv Psychopharmacol. 2023; 13:20451253231200257.

PMID: 37781686 PMC: 10540600. DOI: 10.1177/20451253231200257.